BMDC模型,一种基于细胞的高性能测试,用于评估化学品的敏感化潜力和强度,包括前/前-haptensens
Fabrice Battais1, Isabelle Langonné1, Samuel Muller1
1French Research and Safety Institute for the Prevention of Occupational Accidents and Diseases (INRS), Toxicology and Biomonitoring Division, Vandoeuvre les Nancy, France.
Contact dermatitis
|October 18, 2023
概括
鼠标骨髓衍生树突细胞 (BMDC) 模型准确地识别化学敏感剂,提供高灵敏度和特异性. 这种经过验证的模型预测了敏感性强度,有助于工作场所安全评估.
科学领域:
- 职业健康 职业健康 职业健康 职业健康
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
背景情况:
- 工作场所的化学物质过敏是一个重要的职业健康问题.
- 准确识别化学敏感剂对于风险管理至关重要.
- 此前已经开发了一种小鼠骨髓衍生树突细胞 (BMDC) 模型,用于敏感剂识别.
研究的目的:
- 评估BMDC模型的预测性能.
- 用众所周知的敏感剂和非敏感剂的多样化小组评估其能力.
- 确定模型在分类化学敏感潜力的可靠性.
主要方法:
- 使用BMDC模型进行化学敏感剂评估.
- 通过流细胞计测量测量了六种表型标记物的表达水平.
- 将模型预测与局部淋巴结测试 (LLNA) 标准进行比较.
主要成果:
- BMDC模型正确地分类了81/86的敏感剂和29/37的非敏感剂.
- 实现了高预测值:94%的灵敏度,78%的特异性和89%的准确性.
- 根据EC2值,使敏感剂可以被分为四个强度类 (从极端到弱) 的分类.
结论:
- BMDC模型在区分敏感剂和非敏感剂方面表现出极好的精度.
- 它的预测性能与现有验证的替代模型可比或超过.
- 建议BMDC测试作为一个有价值的工具来评估化学敏感化潜力和功效.
更多相关视频
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
12.3K
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
12.7K
相关概念视频
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Antigens Involved in Adaptive Immunity
511
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
511
